HOME >> BIOLOGY >> NEWS
Top experts and scientists at BioFinland 05 Congress

The congress with its theme Genomic Drug Discovery will approach the entire drug discovery chain from bench to bedside. Identification of targets, validation, and clinical trials are dramatically changing as a consequence of powerful genomics tools being applied in all these areas.

The congress speakers come both from the industry and academia, and they are among others Nobel Laureate (1993) Richard J. Roberts (USA), Leif Groop (Sweden), David R. Cox (USA), Peter Shaw (USA), Kari Alitalo (Finland), Robert G. Pietrusko (USA) and Ruth March (UK).

BioFinland 05 will be held at the Helsinki Fair Centre, April 26 - 27, 2005. The organizers of the congress are Finnish Bioindustries, SITRA (the Finnish National Fund for Research and Development) and Tekes (the Finnish National Technology Agency) as well as the Finnish Fair Corporation.

At the same time, an Investor Forum will be arranged for investors and companies in the bioindustry. Furthermore, there will be ChemBio Finland 05 Exhibition , which will highlight latest innovations and developments within chemical and biotechnology as well as laboratory analytics.

Reduced registration fee until February 28.

For more information on the BioFinland 05 Congress and the speakers: www.biofinland.fi


'"/>

Contact: Ms Saara Hassinen, Assistant Director, Finnish Bioindustries
saara.hassinen@finbio.net
358-917-284-308
Consulate General of Finland
21-Feb-2005


Page: 1

Related biology news :

1. UC experts detail new standard for cleaner transportation fuels
2. Desertification: UN experts prescribe global policy overhaul to avoid looming mass migrations
3. Human ancestors learned to walk upright in the trees, say experts
4. Antarctic lake experts to gather June 6, 7 in Montana
5. Renowned nutrition experts tackle nations obesity problem in new book on primary care nutrition
6. Leading drug discovery and biotechnology scientists and experts discuss latest advancements
7. ALTRAN: Industry experts address technology challenges at Altran Innovation Conference
8. Detaining patients is justified to contain deadly TB strain in South Africa say experts
9. Genetic experts investigate causes of harmful metabolic disorder
10. Specter of possible harm threatens nanotech development, experts say
11. UF experts: Decaffeinated coffee is not caffeine-free

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Top experts and scientists BioFinland Congress

(Date:11/21/2014)... According to a new market ... RFID, Access Control, Intrusion Detection, Parking Management, Under Vehicle ... Service Geography - Global Forecasts to 2020", published by ... be around $25 Billion in 2014 and is expected ... CAGR of 8.69%. Browse 116 market data ...
(Date:11/21/2014)... , Nov. 20, 2014 C-Labs LLC, ... the Internet of Things (IoT), today announced the appointment ... chief operating officer. Previously a strategic advisor to the ... and operations. Mr. Traynor is based out of the ... He reports to Chris Muench , Chief Executive ...
(Date:11/18/2014)... , Nov. 17, 2014   ... and EMC collaborate to develop The Partners Data ... , The Partners Data Lake will allow researcher ... improve diagnostics, treatment and the lives of patients ... research and clinical activities across the Partners system, ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
(Date:12/17/2014)... Based on the revenues gained from surgical imaging ... by four major players contributing to approximately 74% ... GE Healthcare (U.K.), Siemens AG (Germany), Philips (Netherlands), ... Copy at http://www.marketsandmarkets.com/Market-Reports/surgical-imaging-market-210534462.html , The leading ... its strong product portfolio, which includes its flagship ...
(Date:12/17/2014)... Once more, EMAAR has selected ... waste water treatment plant to phase one of BayLaSun, ... Two years ago Bioshaft successfully supplied and operated a ... residential towers with an occupancy of 900 residences. ... gallons per day and was signed on September 16th, ...
(Date:12/17/2014)... Audacity, a leading California-based health and ... the Huntsworth Health Group, is proud to announce the ... her role, Gonzales will serve as Senior Vice President ... to welcome a talent of Jamie’s caliber to the ... “She is a proven healthcare innovation leader and brand ...
(Date:12/17/2014)... SAN FRANCISCO, Calif. , Dec. 17, 2014 ... results of a Phase 2 study evaluating the ... the treatment of patients with severe, chronic itch ... current standard of care, including topical steroids and ... was percent change in Visual Analog Scale (VAS) ...
Breaking Biology Technology:Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 4Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
Cached News: